Skip to content

Pulmonx Corporation LUNG Other current assets

Other current assets at other companies

United Therapeutics logo
United TherapeuticsUTHR
ResMed logo
ResMedRMD
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$20.6M-8.7%
Gross profit$16.0M-1.8%
Operating income-$13.0M+11.0%
Net income-$13.7M+5.5%
EPS (diluted)-$0.33+8.3%

Balance sheet

See full
Cash & equivalents$61.0M-2.4%
Total debt$56.3M-1.2%
Total equity$45.8M-41.1%
Total assets$120.0M-20.4%

Cash flow

See full
Operating cash flow-$10.1M+23.6%
CapEx$9.0K-97.0%
Free cash flow-$10.1M+25.3%

Valuation

See full
Market cap$54.91M-43.7%
Enterprise value$50.17M-39.2%
P/S0.6×-0.5×

Profitability

See full
Gross margin75.5%+2.0pp
Operating margin-58.8%-5.8pp
Net margin-60.1%-4.4pp
FCF margin-33.2%-4.4pp

Returns & leverage

See full
Return on equity-86.2%+62.6pp
Debt / equity1.2×+0.5×
Current ratio4.9×-0.1×

Where this comes from

Reported directly by Pulmonx Corporation in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulmonx Corporation's other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulmonx Corporation's other current assets?
Pulmonx Corporation (LUNG) reported other current assets of $44K in Q1 2026.
How has Pulmonx Corporation's other current assets changed year-over-year?
Pulmonx Corporation's other current assets decreased by 83.9% year-over-year, from $274K to $44K.
What is the long-term trend for Pulmonx Corporation's other current assets?
Over 5 years (2020 to 2025), Pulmonx Corporation's other current assets has grown at a 5.4% compound annual growth rate (CAGR), from $377K to $491K.